Brazil · Delayed Price · Currency is BRL Fleury Earnings Call Transcripts
Fiscal Year 2026
-
Q2 2026 saw double-digit revenue and profit growth, margin expansion, and strong cash generation, driven by robust B2C, B2B, and Lab-to-Lab performance. Strategic acquisitions and disciplined capital allocation supported resilience and future growth.
-
Q1 2026 saw 10.1% revenue growth and 12.2% net income increase, driven by strong B2C and premium brand performance, disciplined capital allocation, and innovation in longevity care. Outlook remains positive with continued market share gains expected.
Fiscal Year 2025
-
Gross revenue grew 12.2% in Q4 2025, driven by strong B2C and New Links performance, with EBITDA and net income up double digits. Strategic acquisitions, disciplined cost management, and digital investments supported stable margins and robust cash generation.
-
Q3 2025 saw 11.5% revenue growth, robust B2C expansion, and strong cash generation. Recent acquisitions in São Paulo and women's health reinforce market leadership, while disciplined capital allocation and high dividend payout continue.
-
Q2 2025 saw modest revenue growth and stable EBITDA, but net income declined due to calendar effects and contract terminations. Investments in digitalization and recent acquisitions support future growth, with a strong cash position and disciplined capital allocation.
-
Q1 2025 saw 6.5% revenue growth and 6.7% net profit increase, driven by strong B2C and regional brand performance, digital transformation, and disciplined cost control. ROIC rose to 16.9%, leverage remained low, and high dividend payouts are expected to continue.
Fiscal Year 2024
-
Strong revenue and EBITDA growth in 2024 was driven by successful integration, strategic acquisitions, and digital innovation. Margins expanded, cash generation was robust, and leverage remained low, positioning the company for continued growth and operational efficiency.
-
Q3 2024 saw 6.1% revenue growth and 9.5% net profit increase, driven by B2B expansion, mobile services, and successful integration with Pardini Group. Margins improved, CapEx rose, and cash generation was strong, with ongoing focus on efficiency and innovation.
-
Q2 2024 saw strong revenue and profit growth, driven by the successful integration with Pardini, margin expansion, and disciplined capital allocation. B2C and B2B segments both posted double-digit growth, with synergies and operational efficiency supporting results.